Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05445843 |
|---|---|
| Brief Title: | Study of Efficacy and Safety of JDQ443 Single-agent as First-line Treatment for Patients With Locally Advanced or Metastatic KRAS G12C- Mutated Non-small Cell Lung Cancer With a PD-L1 Expression < 1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation. |
| First Submitted : | June 30, 2022 |
| First Submitted that Met QC Criteria : | June 30, 2022 |
| First Posted : | July 6, 2022 |
| Last Update Submitted that Met QC Criteria : | February 27, 2024 |
| Last Update Posted : | February 28, 2024 |